An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum

Journal of Infectious Diseases

Volumn 175, Issue 5, 1997, Pages 1268-1272

  Verdon, Renaud ^b   Keusch, Gerald T ^b   Tzipori, Saul ^b   Grubman, Shelley A ^b   Jefferson, Douglas M ^b   Ward, Honorine D ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PAROMOMYCIN;

ARTICLE; CELL CULTURE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INOCULATION; INTRAHEPATIC BILE DUCT; OOCYST; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0030898790     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/593695     Document Type: Article

References (13)

1. Current WL, Garcia LS. Cryptosporidiosis. Clin Microbiol Rev 1991;4:325-58.
2. Buraud M, Forget E, Favennec L, Bizet J, Gobert JG, Deluol AM. Sexual stage development of cryptosporidia in the Caco-2 cell line. Infect Immun 1991;59:4610-3.
3. Gut J, Petersen C, Nelson R, Leech J. Cryptosporidium parvum: in vitro cultivation in Madin-Darby canine kidney cells. J Protozool 1991;38:72S-3S.
4. Marshall RJ, Flanigan TP. Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. J Infect Dis 1992;165:772-4.
5. McDonald V, Stables R, Warhurst DC, et al. In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrob Agents Chemother 1990;34:1498-500.
6. Upton SJ, Tilley M, Brillhart DB. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol Lett 1994;118:233-6.
7. Tzipori ST, Rand W, Theodos C. Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-γ monoclonal antibody for drug testing against Cryptosporidium parvum. J Infect Dis 1995;172:1160-4.
8. Hamer DH, Ward H, Tzipori S, et al. Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Infect Immun 1994;62:2208-13.
9. Vakil NB, Schwartz SM, Buggy BP, et al. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996;334:19-23.
10. Mead JR, Ilksoy N, You X, et al. Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect Immun 1994;62:1691-5.
11. Ungar BLP, Burris JA, Quinn CA, Finkelman FD. New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect Immun 1990;58:961-9.
12. Woods KM, Nesterenko MV, Upton SJ. Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro. FEMS Microbiol Lett 1995;128:89-94.
13. Favennec L, Egraz-Bernard M, Comby E, Lemeteil D, Ballet JJ, Brasseur P. Immunofluorescence detection of Cryptosporidium parvum in Caco-2 cells: a new screening method for anticryptosporidial agents. J Eukaryot Microbiol 1994;41:39S.